Maksym Tarasenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maksym Tarasenko has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Lesya Lymar
Bogomolets National Medical University, Kyiv, Ukraine
1 shared publication - Oleksandr Naumenko
Bogomolets National Medical University
1 shared publication - Roman Romanenko
University Clinic of the National Medical University named after O. O. Bogomolets, Kyiv, Ukraine
1 shared publication - Sergey Dovgich
University Clinic of the National Medical University named after O. O. Bogomolets, Kyiv, Ukraine; KNP "St. Michael's Clinical Hospital of Kyiv", Kyiv, Ukraine
1 shared publication - Serhii Konovalov
Bogomolets National Medical University
1 shared publication - Snizhana I. Laziuk
Student, Bogomolets National Medical University, Kyiv, Ukraine
1 shared publication
Latest Publications
- Open Access
- 29 June 2025
- Published by Bogomolets National Medical University in Ukrainian Scientific Medical Youth Journal
- Vol. 154 (2) , 10-16
A case of nosebleeds in Osler-Weber-Rend syndrome
Hereditary hemorrhagic telangiectasia (HHT), or Osler-Weber-Rend syndrome, is a genetic autosomal dominant disease. The cause of HHT is mutations in genes involved in angiogenesis, primarily ENG, ACVRL1 and SMAD4, which leads to vascular dysplasia and, as a result, telangiectasias, recurrent bleeding and arteriovenous malformations. The prevalence of HHT is 1 in 5,000-10,000 people. HHT can occur at any age, and symptoms can vary greatly in different people due to the nature of genetic mutations, which complicates diagnosis. To focus the attention of the medical community on HHT and to promote the development of effective approaches to its diagnosis and therapy of HHT, particularly in the context of epistaxis. The study analyzed the experience of treating a patient with hereditary hemorrhagic telangiectasia (HHT), who presented with complaints of epistaxis. The patient was clinically examined and treated according to the Ukrainian Unified Clinical Protocol for the Treatment of Epistaxis. The following treatments were used: hemostatic tampons, to temporarily stop nasal bleeding due to their ability to quickly absorb blood and create mechanical pressure on the bleeding site; fibrin thread swabs, which were used to improve hemostasis and stimulate the natural blood clotting process; diathermy, as local cauterization of bleeding areas of the nasal mucosa to reduce bleeding; hormonal therapy with dexamethasone, which was used to reduce inflammation and reduce the frequency of bleeding; antifibrinolytic therapy with tranexamic acid, to inhibit fibrinolysis and reduce the risk of recurrent bleeding; and anti-inflammatory therapy with diclofenac, which was prescribed to reduce pain, swelling, and inflammation in patients with complications of nosebleeds. A 76-year-old woman was brought to the otolaryngology department with recurrent epistaxis. The patient was diagnosed with SGT according to the Curacao diagnostic criteria (Clinical guideline of the French Association of Otorhinolaryngologists from 2016) based on clinical data, medical history, and family history. Treatment was carried out using non-surgical methods of treatment and consultation with such doctors as: geneticist, rheumatologist, gastroenterologist. After the therapy, the woman was discharged 2 weeks after admission in a satisfactory condition with recommendations for preventing bleeding. This case emphasizes the importance of early diagnosis of SHT, an individual approach to treatment and the need to expand the possibilities of SHT treatment in Ukraine.
- 29 June 2025
- Published by Bogomolets National Medical University in Ukrainian Scientific Medical Youth Journal
- Vol. 154 (2) , 10-16
Open AccessA case of nosebleeds in Osler-Weber-Rend syndrome
Hereditary hemorrhagic telangiectasia (HHT), or Osler-Weber-Rend syndrome, is a genetic autosomal dominant disease. The cause of HHT is mutations in genes involved in angiogenesis, primarily ENG, ACVRL1 and SMAD4, which leads to vascular dysplasia and, as a result, telangiectasias, recurrent bleeding and arteriovenous malformations. The prevalence of HHT is 1 in 5,000-10,000 people. HHT can occur at any age, and symptoms can vary greatly in different people due to the nature of genetic mutations, which complicates diagnosis. To focus the attention of the medical community on HHT and to promote the development of effective approaches to its diagnosis and therapy of HHT, particularly in the context of epistaxis. The study analyzed the experience of treating a patient with hereditary hemorrhagic telangiectasia (HHT), who presented with complaints of epistaxis. The patient was clinically examined and treated according to the Ukrainian Unified Clinical Protocol for the Treatment of Epistaxis. The following treatments were used: hemostatic tampons, to temporarily stop nasal bleeding due to their ability to quickly absorb blood and create mechanical pressure on the bleeding site; fibrin thread swabs, which were used to improve hemostasis and stimulate the natural blood clotting process; diathermy, as local cauterization of bleeding areas of the nasal mucosa to reduce bleeding; hormonal therapy with dexamethasone, which was used to reduce inflammation and reduce the frequency of bleeding; antifibrinolytic therapy with tranexamic acid, to inhibit fibrinolysis and reduce the risk of recurrent bleeding; and anti-inflammatory therapy with diclofenac, which was prescribed to reduce pain, swelling, and inflammation in patients with complications of nosebleeds. A 76-year-old woman was brought to the otolaryngology department with recurrent epistaxis. The patient was diagnosed with SGT according to the Curacao diagnostic criteria (Clinical guideline of the French Association of Otorhinolaryngologists from 2016) based on clinical data, medical history, and family history. Treatment was carried out using non-surgical methods of treatment and consultation with such doctors as: geneticist, rheumatologist, gastroenterologist. After the therapy, the woman was discharged 2 weeks after admission in a satisfactory condition with recommendations for preventing bleeding. This case emphasizes the importance of early diagnosis of SHT, an individual approach to treatment and the need to expand the possibilities of SHT treatment in Ukraine.
- Open Access
- 26 December 2024
- Published by Private Company Technology Center in ScienceRise: Medical Science
- No. 4 (61),p. 4-10
Validation of the Ukrainian version of the tinnitus quality of life assessment questionnaire "Tinnitus Handicap Inventory"
Tinnitus (the sensation of ringing or noise in the ears) is a common condition, particularly associated with hearing impairments, and significantly affects patients' quality of life, especially due to disturbances in sleep, concentration, and the deterioration of emotional well-being. One of the most widely used tools for assessing the severity of tinnitus symptoms is the Tinnitus Handicap Inventory (THI) questionnaire. It was developed to comprehensively evaluate the impact of tinnitus on various aspects of a patient's life, and as a result, this questionnaire has gained international recognition. Validating the Ukrainian version of the Tinnitus Handicap Inventory will ensure the accuracy and reliability of data related to the impact of tinnitus on patients. It will allow for the integration of the tool into clinical practice for more effective monitoring of patient status and selection of optimal treatment methods. The aim of the study: To validate the Ukrainian version of the "Tinnitus Handicap Inventory" questionnaire for evaluating the quality of life of patients with tinnitus. Materials and methods: A total of 65 individuals participated in the study. Based on the established diagnosis of sudden sensorineural hearing loss (35 individuals) or chronic sensorineural hearing loss (30 individuals), the patients were divided into Group A and Group B. The study design involved conducting questionnaires, otolaryngological examinations, and full audiological assessments. The questionnaires were administered to all patients twice — at the time of hospitalization and discharge from the otolaryngology department. Two questionnaires were used: the Tinnitus Handicap Inventory and a 10-point VAS (Visual Analog Scale) for quality of life. Results: When evaluating dynamic changes in THI questionnaire data during treatment, patients with sensorineural hearing loss (SNHL) and tinnitus showed statistically significant changes between the initial and follow-up measurements (p0.8), and the validation of the questionnaire is complete. Conclusions: According to current data, the Tinnitus Handicap Inventory consists of 25 simple questions and has several advantages over other scales or questionnaires, including its widespread use and integration into otolaryngological and neurological practice. This questionnaire is one of the most recognized and frequently used tools to assess tinnitus's impact on patients' quality of life worldwide. The Ukrainian version of the Tinnitus Handicap Inventory has successfully passed psychometric evaluation, making it sensitive, reliable, and valid. All stages of validation of the Ukrainian adapted translation of the Tinnitus Handicap Inventory have been successfully completed, and its use in clinical practice for assessing the quality of life of patients with tinnitus is therefore justified
- 26 December 2024
- Published by Private Company Technology Center in ScienceRise: Medical Science
- No. 4 (61),p. 4-10
Open AccessValidation of the Ukrainian version of the tinnitus quality of life assessment questionnaire "Tinnitus Handicap Inventory"
Tinnitus (the sensation of ringing or noise in the ears) is a common condition, particularly associated with hearing impairments, and significantly affects patients' quality of life, especially due to disturbances in sleep, concentration, and the deterioration of emotional well-being. One of the most widely used tools for assessing the severity of tinnitus symptoms is the Tinnitus Handicap Inventory (THI) questionnaire. It was developed to comprehensively evaluate the impact of tinnitus on various aspects of a patient's life, and as a result, this questionnaire has gained international recognition. Validating the Ukrainian version of the Tinnitus Handicap Inventory will ensure the accuracy and reliability of data related to the impact of tinnitus on patients. It will allow for the integration of the tool into clinical practice for more effective monitoring of patient status and selection of optimal treatment methods. The aim of the study: To validate the Ukrainian version of the "Tinnitus Handicap Inventory" questionnaire for evaluating the quality of life of patients with tinnitus. Materials and methods: A total of 65 individuals participated in the study. Based on the established diagnosis of sudden sensorineural hearing loss (35 individuals) or chronic sensorineural hearing loss (30 individuals), the patients were divided into Group A and Group B. The study design involved conducting questionnaires, otolaryngological examinations, and full audiological assessments. The questionnaires were administered to all patients twice — at the time of hospitalization and discharge from the otolaryngology department. Two questionnaires were used: the Tinnitus Handicap Inventory and a 10-point VAS (Visual Analog Scale) for quality of life. Results: When evaluating dynamic changes in THI questionnaire data during treatment, patients with sensorineural hearing loss (SNHL) and tinnitus showed statistically significant changes between the initial and follow-up measurements (p0.8), and the validation of the questionnaire is complete. Conclusions: According to current data, the Tinnitus Handicap Inventory consists of 25 simple questions and has several advantages over other scales or questionnaires, including its widespread use and integration into otolaryngological and neurological practice. This questionnaire is one of the most recognized and frequently used tools to assess tinnitus's impact on patients' quality of life worldwide. The Ukrainian version of the Tinnitus Handicap Inventory has successfully passed psychometric evaluation, making it sensitive, reliable, and valid. All stages of validation of the Ukrainian adapted translation of the Tinnitus Handicap Inventory have been successfully completed, and its use in clinical practice for assessing the quality of life of patients with tinnitus is therefore justified